iRhythm Technologies, Inc.

NASDAQ:IRTC

Medical - Devices

Healthcare
$94.87 +0.35%

+$0.36 today

Market cap
$3.19B
Beta
1.28
P/E (TTM)
-119.5
EPS (TTM)
-$0.85
52W Low $100.85High $212.00

Volume 1.20M

Average 0.52M

IRTC Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

iRhythm Technologies, Inc.NASDAQ: IRTC

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin widens to 74.2%

Gross margin was 74.2% in Q3 FY2026, up 3.1 pp from a year earlier. On a trailing-twelve-month basis it was 72.3%, up 1.9 pp year over year. Over 3 fiscal years it widened by 2.0 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
74.2%+1.4 pp QoQ
Last fiscal yearDec 2025
70.6%+1.7 pp YoY
LTMSep 2026
72.3%+1.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.1 pp——
1 year+1.7 pp——
3 years+2.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
70.6%
Year-over-year change
+1.7pp

Gross Margin vs competitors

How IRTC compares with its peers on the latest reported figures

  • IRTC's LTM Sep 2026 gross margin of 72.3% is the 2nd highest of the 7 companies compared; the peer median is 67.9%.
  • Its year-over-year change of +1.9 pp is the 4th highest of 7, against a peer median of +2.4 pp.
  • Over three fiscal years its change of +2.0 pp compares with a peer median of -0.0 pp.
IRTC Competitors Peer median
Gross Margin for IRTC and competitors
Company Period LTM level YoY 3-year change
ATRCAtriCure, Inc.LTM Jun 202676.2% +1.5 pp-0.0 pp
IRTCiRhythm Technologies, Inc.LTM Sep 202672.3% +1.9 pp+2.0 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
PENPenumbra, Inc.LTM Jun 202667.8% +1.4 pp+4.0 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
KMTSKestra Medical Technologies, Ltd.LTM Jan 202648.8% +14.6 pp—
Peer median (excluding IRTC) 67.9%+2.4 pp-0.0 pp

Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue322.83M410.92M492.68M591.84M747.14M
Cost of Revenue109.26M129.29M160.88M184.31M219.89M
Gross Profit213.57M281.63M331.81M407.53M527.25M
Gross Margin66.2%68.5%67.3%68.9%70.6%
Research & Development38.67M46.61M60.24M103.83M84.61M
Selling, General & Admin274.84M322.2M385.65M418.57M479.45M
Operating Expenses313.51M395.42M456.97M523.04M564.06M
Depreciation & Amortization16.59M19.61M22.14M25.78M26.48M
EBITDA(83.23M)(92.14M)(96.86M)(74.13M)(3.97M)
EBITDA Margin-25.8%-22.4%-19.7%-12.5%-0.5%
Operating Income(99.94M)(113.78M)(125.16M)(115.51M)(36.81M)
Operating Margin-31.0%-27.7%-25.4%-19.5%-4.9%
Interest Income118K2.35M6.16M21.94M21.52M
Interest Expense1.17M4.14M3.65M12.82M13.15M
Other Income / Expenses(1.05M)(2.1M)2.51M2.78M(6.79M)
Income Before Tax(100.99M)(115.89M)(122.66M)(112.72M)(43.6M)
Pre-Tax Margin-31.3%-28.2%-24.9%-19.0%-5.8%
Income Tax Expense367K269K750K565K953K
Net Income(101.36M)(116.16M)(123.41M)(113.29M)(44.55M)
Net Margin-31.4%-28.3%-25.0%-19.1%-6.0%
EPS (Basic)(3.46)(3.88)(4.04)(3.63)(1.39)
EPS (Diluted)(3.46)(3.88)(4.04)(3.63)(1.39)
Weighted Avg Shares29.33M29.92M30.53M31.2M32M
Weighted Avg Shares (Diluted)29.33M29.92M30.53M31.2M32M

iRhythm Technologies, Inc.

NASDAQ:IRTC

Intrinsic Alpha fair value

Locked

Current Price

$94.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.